Intuitive Surgical (NASDAQ: ISRG) and Bruker Corporation (NASDAQ:BRKR) are both mid-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, dividends, valuation, earnings, risk, analyst recommendations and profitability.
Institutional and Insider Ownership
96.1% of Intuitive Surgical shares are owned by institutional investors. Comparatively, 66.4% of Bruker Corporation shares are owned by institutional investors. 2.5% of Intuitive Surgical shares are owned by insiders. Comparatively, 35.2% of Bruker Corporation shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Bruker Corporation pays an annual dividend of $0.16 per share and has a dividend yield of 0.6%. Intuitive Surgical does not pay a dividend. Bruker Corporation pays out 16.0% of its earnings in the form of a dividend.
This table compares Intuitive Surgical and Bruker Corporation’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Earnings and Valuation
This table compares Intuitive Surgical and Bruker Corporation’s top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Intuitive Surgical||$2.87 billion||12.80||$1.08 billion||$20.88||47.36|
|Bruker Corporation||$1.66 billion||2.67||$275.00 million||$1.00||27.97|
Intuitive Surgical has higher revenue and earnings than Bruker Corporation. Bruker Corporation is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.
Volatility & Risk
Intuitive Surgical has a beta of 0.39, meaning that its share price is 61% less volatile than the S&P 500. Comparatively, Bruker Corporation has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500.
This is a breakdown of recent recommendations and price targets for Intuitive Surgical and Bruker Corporation, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Intuitive Surgical currently has a consensus price target of $972.20, suggesting a potential downside of 1.69%. Bruker Corporation has a consensus price target of $26.25, suggesting a potential downside of 6.15%. Given Intuitive Surgical’s stronger consensus rating and higher probable upside, analysts plainly believe Intuitive Surgical is more favorable than Bruker Corporation.
Intuitive Surgical beats Bruker Corporation on 12 of the 16 factors compared between the two stocks.
About Intuitive Surgical
Intuitive Surgical, Inc. (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. The da Vinci Surgical System provides its operating surgeons with control, range of motion, tissue manipulation capability and three-dimensional (3-D), high-definition (HD) vision. Intuitive has four generations of da Vinci Surgical System: the da Vinci Xi Surgical System, the da Vinci Si Surgical System, the da Vinci S Surgical System and the standard da Vinci Surgical System. The Company’s instruments and accessories include EndoWrist Instruments and da Vinci Single-Site.
About Bruker Corporation
Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. The Bruker BioSpin Group segment designs, manufactures and distributes enabling life science tools. The Bruker CALID segment designs, manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as chemical, biological, radiological, nuclear and explosive detection products. The Bruker Nano segment designs, manufactures and distributes spectroscopy and microscopy instruments. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices. It also focuses on nanomechanical testing instruments.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with our FREE daily email newsletter.